Neurorestoration induced by mesenchymal stem cells

Potential therapeutic mechanisms for clinical trials

Jung Hwa Seo, Sung-Rae Cho

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Stem cells are emerging as therapeutic candidates in a variety of diseases because of their multipotent capacities. Among these, mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord blood or adipose tissue, comprise a population of cells that exhibit extensive proliferative potential and retain the ability to differentiate into multiple tissue-specific lineage cells including osteoblasts, chondrocytes, and adipocytes. MSCs have also been shown to enhance neurological recovery, although the therapeutic effects seem to be derived from an indirect paracrine effect rather than direct cell replacement. MSCs secrete neurotrophic factors, promote endogenous neurogenesis and angiogenesis, encourage synaptic connection and remyelination of damaged axons, decrease apoptosis, and regulate inflammation primarily through paracrine actions. Accordingly, MSCs may prevail as a promising cell source for cell-based therapy in neurological diseases.

Original languageEnglish
Pages (from-to)1059-1067
Number of pages9
JournalYonsei medical journal
Volume53
Issue number6
DOIs
Publication statusPublished - 2012 Nov 1

Fingerprint

Mesenchymal Stromal Cells
Clinical Trials
Neurogenesis
Nerve Growth Factors
Therapeutic Uses
Therapeutics
Chondrocytes
Cell- and Tissue-Based Therapy
Osteoblasts
Fetal Blood
Adipocytes
Axons
Adipose Tissue
Stem Cells
Bone Marrow
Apoptosis
Inflammation
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{2514ee3bcba942548b06d06f906f9c90,
title = "Neurorestoration induced by mesenchymal stem cells: Potential therapeutic mechanisms for clinical trials",
abstract = "Stem cells are emerging as therapeutic candidates in a variety of diseases because of their multipotent capacities. Among these, mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord blood or adipose tissue, comprise a population of cells that exhibit extensive proliferative potential and retain the ability to differentiate into multiple tissue-specific lineage cells including osteoblasts, chondrocytes, and adipocytes. MSCs have also been shown to enhance neurological recovery, although the therapeutic effects seem to be derived from an indirect paracrine effect rather than direct cell replacement. MSCs secrete neurotrophic factors, promote endogenous neurogenesis and angiogenesis, encourage synaptic connection and remyelination of damaged axons, decrease apoptosis, and regulate inflammation primarily through paracrine actions. Accordingly, MSCs may prevail as a promising cell source for cell-based therapy in neurological diseases.",
author = "Seo, {Jung Hwa} and Sung-Rae Cho",
year = "2012",
month = "11",
day = "1",
doi = "10.3349/ymj.2012.53.6.1059",
language = "English",
volume = "53",
pages = "1059--1067",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "6",

}

Neurorestoration induced by mesenchymal stem cells : Potential therapeutic mechanisms for clinical trials. / Seo, Jung Hwa; Cho, Sung-Rae.

In: Yonsei medical journal, Vol. 53, No. 6, 01.11.2012, p. 1059-1067.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Neurorestoration induced by mesenchymal stem cells

T2 - Potential therapeutic mechanisms for clinical trials

AU - Seo, Jung Hwa

AU - Cho, Sung-Rae

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Stem cells are emerging as therapeutic candidates in a variety of diseases because of their multipotent capacities. Among these, mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord blood or adipose tissue, comprise a population of cells that exhibit extensive proliferative potential and retain the ability to differentiate into multiple tissue-specific lineage cells including osteoblasts, chondrocytes, and adipocytes. MSCs have also been shown to enhance neurological recovery, although the therapeutic effects seem to be derived from an indirect paracrine effect rather than direct cell replacement. MSCs secrete neurotrophic factors, promote endogenous neurogenesis and angiogenesis, encourage synaptic connection and remyelination of damaged axons, decrease apoptosis, and regulate inflammation primarily through paracrine actions. Accordingly, MSCs may prevail as a promising cell source for cell-based therapy in neurological diseases.

AB - Stem cells are emerging as therapeutic candidates in a variety of diseases because of their multipotent capacities. Among these, mesenchymal stem cells (MSCs) derived from bone marrow, umbilical cord blood or adipose tissue, comprise a population of cells that exhibit extensive proliferative potential and retain the ability to differentiate into multiple tissue-specific lineage cells including osteoblasts, chondrocytes, and adipocytes. MSCs have also been shown to enhance neurological recovery, although the therapeutic effects seem to be derived from an indirect paracrine effect rather than direct cell replacement. MSCs secrete neurotrophic factors, promote endogenous neurogenesis and angiogenesis, encourage synaptic connection and remyelination of damaged axons, decrease apoptosis, and regulate inflammation primarily through paracrine actions. Accordingly, MSCs may prevail as a promising cell source for cell-based therapy in neurological diseases.

UR - http://www.scopus.com/inward/record.url?scp=84868112172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868112172&partnerID=8YFLogxK

U2 - 10.3349/ymj.2012.53.6.1059

DO - 10.3349/ymj.2012.53.6.1059

M3 - Review article

VL - 53

SP - 1059

EP - 1067

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 6

ER -